BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31677330)

  • 21. WNT Signaling in osteoarthritis and osteoporosis: what is the biological significance for the clinician?
    Lodewyckx L; Lories RJ
    Curr Rheumatol Rep; 2009 Feb; 11(1):23-30. PubMed ID: 19171108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secreted frizzled-related proteins are required for Wnt/β-catenin signalling activation in the vertebrate optic cup.
    Esteve P; Sandonìs A; Ibañez C; Shimono A; Guerrero I; Bovolenta P
    Development; 2011 Oct; 138(19):4179-84. PubMed ID: 21896628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GSK3-activated STAT5 regulates expression of SFRPs to modulate adipogenesis.
    Wang L; Wang Y; Meng Y; Zhang C; Di L
    FASEB J; 2018 Sep; 32(9):4714-4726. PubMed ID: 29579399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GDF5 reduces MMP13 expression in human chondrocytes via DKK1 mediated canonical Wnt signaling inhibition.
    Enochson L; Stenberg J; Brittberg M; Lindahl A
    Osteoarthritis Cartilage; 2014 Apr; 22(4):566-77. PubMed ID: 24561281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wnt signaling in osteosarcoma.
    Lin CH; Ji T; Chen CF; Hoang BH
    Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway.
    Sun X; He Y; Huang C; Ma TT; Li J
    Cell Signal; 2013 Dec; 25(12):2805-11. PubMed ID: 24041653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of genetic and epigenetic mechanisms to Wnt pathway activity in prevalent skeletal disorders.
    García-Ibarbia C; Delgado-Calle J; Casafont I; Velasco J; Arozamena J; Pérez-Núñez MI; Alonso MA; Berciano MT; Ortiz F; Pérez-Castrillón JL; Fernández AF; Fraga MF; Zarrabeitia MT; Riancho JA
    Gene; 2013 Dec; 532(2):165-72. PubMed ID: 24096177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wnt/β-catenin Signaling in Osteoarthritis and in Other Forms of Arthritis.
    Zhou Y; Wang T; Hamilton JL; Chen D
    Curr Rheumatol Rep; 2017 Sep; 19(9):53. PubMed ID: 28752488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a bioassay for detection of Wnt-binding affinities for individual frizzled receptors.
    Carmon KS; Loose DS
    Anal Biochem; 2010 Jun; 401(2):288-94. PubMed ID: 20227380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WNT Signaling and Bone: Lessons From Skeletal Dysplasias and Disorders.
    Huybrechts Y; Mortier G; Boudin E; Van Hul W
    Front Endocrinol (Lausanne); 2020; 11():165. PubMed ID: 32328030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The crystal structure of full-length Sizzled from
    Bu Q; Li Z; Zhang J; Xu F; Liu J; Liu H
    J Biol Chem; 2017 Sep; 292(39):16055-16069. PubMed ID: 28808056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of WNTs and FRPs in the synovium of rheumatoid arthritis and osteoarthritis.
    Imai K; Morikawa M; D'Armiento J; Matsumoto H; Komiya K; Okada Y
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1615-20. PubMed ID: 16735027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Interaction between microRNAs and the Wnt/β-Catenin Signaling Pathway in Osteoarthritis.
    Shang X; Böker KO; Taheri S; Hawellek T; Lehmann W; Schilling AF
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue.
    Ehrlund A; Mejhert N; Lorente-Cebrián S; Aström G; Dahlman I; Laurencikiene J; Rydén M
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E503-8. PubMed ID: 23393180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based prediction of Wnt binding affinities for Frizzled-type cysteine-rich domains.
    Agostino M; Pohl SÖ; Dharmarajan A
    J Biol Chem; 2017 Jul; 292(27):11218-11229. PubMed ID: 28533339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Wnt/β-catenin negative feedback loop inhibits interleukin-1-induced matrix metalloproteinase expression in human articular chondrocytes.
    Ma B; van Blitterswijk CA; Karperien M
    Arthritis Rheum; 2012 Aug; 64(8):2589-600. PubMed ID: 22328140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A secreted splice variant of the Xenopus frizzled-4 receptor is a biphasic modulator of Wnt signalling.
    Gorny AK; Kaufmann LT; Swain RK; Steinbeisser H
    Cell Commun Signal; 2013 Nov; 11():89. PubMed ID: 24252524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Wnt signaling pathway and bone metabolism.
    Johnson ML; Kamel MA
    Curr Opin Rheumatol; 2007 Jul; 19(4):376-82. PubMed ID: 17551370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cushioning the cartilage: a canonical Wnt restricting matter.
    Monteagudo S; Lories RJ
    Nat Rev Rheumatol; 2017 Nov; 13(11):670-681. PubMed ID: 29021569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. sFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease.
    Warrier S; Marimuthu R; Sekhar S; Bhuvanalakshmi G; Arfuso F; Das AK; Bhonde R; Martins R; Dharmarajan A
    Int J Biochem Cell Biol; 2016 Jun; 75():104-11. PubMed ID: 27063405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.